Media Summary: Hanny Al-Samkari, MD, Massachusetts General Hospital, Boston, MA, comments on the current Hanny Al-Samkari, MD, Massachusetts General Hospital, Boston, MA, highlights the challenges associated with Podcast Show Notes: Topic: Febrile neutropenia,

Chemotherapy Induced Thrombocytopenia Shifting Treatment - Detailed Analysis & Overview

Hanny Al-Samkari, MD, Massachusetts General Hospital, Boston, MA, comments on the current Hanny Al-Samkari, MD, Massachusetts General Hospital, Boston, MA, highlights the challenges associated with Podcast Show Notes: Topic: Febrile neutropenia, ... romlo with simultaneously with pilgressive or ithropotin in Cathy continues her coverage of common complications associated with cancer ... heparin (LMWH) in patients with cancer-associated thrombosis who develop

A 64-year-old with metastatic colorectal cancer on oxaliplatin-based multiagent Mario Dicato, MD, Hematology-Oncology Service, Centre Hospitalier de Luxembourg, discusses 3 agents used for the This study investigates the effectiveness of the drug romiplostim in managing a frequent cancer

Photo Gallery

Chemotherapy-induced thrombocytopenia: shifting treatment strategies and the use of TPOR agonists
Challenges associated with managing chemotherapy-induced thrombocytopenia
Chemotherapy-induced thrombocytopenia: what you need to know about low platelets. #podcast #oncology
Chemotherapy-Induced Thrombocytopenia: New Solutions for an Old Problem
Neutropenia, Anemia, Thrombocytopenia - Medical-Surgical (Immune) | @LevelUpRN
Presentation #3: Managing Menorrhagia in Women with Chemotherapy-Induced ...
Guidance for anticoagulation management in the setting of thrombocytopenia in cancer patients
Persistent chemo-induced thrombocytopenia: do you hold chemo again—or add a TPO-RA?
Febrile Neutropenia, Thrombocytopenia, and Anaemia
Dr. Dicato on Agents to Treat Thrombocytopenia for Patients With Cancer
Febrile Neutropenia, Thrombocytopenia, and Anaemia
NEJM March 12 2026 Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia
View Detailed Profile
Chemotherapy-induced thrombocytopenia: shifting treatment strategies and the use of TPOR agonists

Chemotherapy-induced thrombocytopenia: shifting treatment strategies and the use of TPOR agonists

Hanny Al-Samkari, MD, Massachusetts General Hospital, Boston, MA, comments on the current

Challenges associated with managing chemotherapy-induced thrombocytopenia

Challenges associated with managing chemotherapy-induced thrombocytopenia

Hanny Al-Samkari, MD, Massachusetts General Hospital, Boston, MA, highlights the challenges associated with

Chemotherapy-induced thrombocytopenia: what you need to know about low platelets. #podcast #oncology

Chemotherapy-induced thrombocytopenia: what you need to know about low platelets. #podcast #oncology

Podcast Show Notes: Topic: Febrile neutropenia,

Chemotherapy-Induced Thrombocytopenia: New Solutions for an Old Problem

Chemotherapy-Induced Thrombocytopenia: New Solutions for an Old Problem

... romlo with simultaneously with pilgressive or ithropotin in

Neutropenia, Anemia, Thrombocytopenia - Medical-Surgical (Immune) | @LevelUpRN

Neutropenia, Anemia, Thrombocytopenia - Medical-Surgical (Immune) | @LevelUpRN

Cathy continues her coverage of common complications associated with cancer

Presentation #3: Managing Menorrhagia in Women with Chemotherapy-Induced ...

Presentation #3: Managing Menorrhagia in Women with Chemotherapy-Induced ...

Presentation #3: Women with

Guidance for anticoagulation management in the setting of thrombocytopenia in cancer patients

Guidance for anticoagulation management in the setting of thrombocytopenia in cancer patients

... heparin (LMWH) in patients with cancer-associated thrombosis who develop

Persistent chemo-induced thrombocytopenia: do you hold chemo again—or add a TPO-RA?

Persistent chemo-induced thrombocytopenia: do you hold chemo again—or add a TPO-RA?

A 64-year-old with metastatic colorectal cancer on oxaliplatin-based multiagent

Febrile Neutropenia, Thrombocytopenia, and Anaemia

Febrile Neutropenia, Thrombocytopenia, and Anaemia

Podcast Show Notes: Topic: Febrile neutropenia,

Dr. Dicato on Agents to Treat Thrombocytopenia for Patients With Cancer

Dr. Dicato on Agents to Treat Thrombocytopenia for Patients With Cancer

Mario Dicato, MD, Hematology-Oncology Service, Centre Hospitalier de Luxembourg, discusses 3 agents used for the

Febrile Neutropenia, Thrombocytopenia, and Anaemia

Febrile Neutropenia, Thrombocytopenia, and Anaemia

Podcast Show Notes: • Topic: Febrile neutropenia,

NEJM March 12 2026 Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia

NEJM March 12 2026 Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia

This study investigates the effectiveness of the drug romiplostim in managing a frequent cancer

Webinar: Chemotherapy-induced peripheral neuropathy: the role of the brain & exercise as treatment

Webinar: Chemotherapy-induced peripheral neuropathy: the role of the brain & exercise as treatment

Title: